Beam Therapeutics Inc. (BEAM) Insider Ownership

Historic Insider Ownership Trends

BEAM's three largest insider shareholders as of March 23, 2026 are Robert Nelsen (Director, 3.54Mn shares), Venture Partners Ix, Llc Arch (TenPercentOwner, 2.95Mn shares), Kristina Burow (Director, 2.93Mn shares).

Top Direct Holders

Insider ownership data is derived from the last 60 months of Form 4 SEC filings.
Holder Position Shares (Direct) Shares (Indirect) Report Date
Robert Nelsen 14,053 3,521,519 02 Apr, 2021
Venture Partners Ix, Llc Arch 28,111 2,921,519 02 Jul, 2021
Kristina Burow 12,067 2,921,519 02 Jul, 2021
John M. Evans Ceo 986,667 0 02 Feb, 2026
Giuseppe Ciaramella President 190,216 0 26 Feb, 2026
John M. Evans Ceo 0 103,000 02 Nov, 2022
Christine Bellon Chief Legal Officer 95,667 0 26 Jan, 2026
Terry-Ann Burrell Chief Financial Officer 82,637 0 29 Apr, 2024
Amy Simon Chief Medical Officer 77,364 0 05 Jan, 2026
Sravan Kumar Emany Chief Financial Officer 73,706 0 05 Jan, 2026
Bethany J Cavanagh Svp, Finance And Treasurer 34,813 0 26 Jan, 2026
Llc Fmr 0 14 29 Oct, 2025

* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.

Recent Insider Transactions

Detailed insider trading activity based on Form 4 SEC filings.
Download Data
Transaction Date Insider Name Security Class Transaction Type Shares Traded Price Shares Remaining Ownership Code
24 Feb, 2026 Giuseppe Ciaramella Common Stock A 35,000 $17.00 225,216 D M
24 Feb, 2026 Giuseppe Ciaramella Common Stock D 35,000 $32.00 190,216 D S
24 Feb, 2026 Giuseppe Ciaramella Stock Option (Right to Buy) D 35,000 $0.00 397,313 D M
31 Jan, 2026 Giuseppe Ciaramella Stock Option (Right to Buy) A 80,000 $0.00 80,000 D A
31 Jan, 2026 Sravan Kumar Emany Stock Option (Right to Buy) A 63,500 $0.00 63,500 D A
31 Jan, 2026 Bethany J Cavanagh Stock Option (Right to Buy) A 40,000 $0.00 40,000 D A
31 Jan, 2026 Christine Bellon Stock Option (Right to Buy) A 40,000 $0.00 40,000 D A
29 Jan, 2026 John M. Evans Common Stock A 19,336 $0.67 1,006,003 D M
31 Jan, 2026 Amy Simon Stock Option (Right to Buy) A 88,500 $0.00 88,500 D A
29 Jan, 2026 John M. Evans Common Stock A 5,664 $0.67 1,011,667 D M
29 Jan, 2026 John M. Evans Common Stock D 16,333 $29.19 995,334 D S
29 Jan, 2026 John M. Evans Common Stock D 8,667 $29.74 986,667 D S
30 Jan, 2026 John M. Evans Common Stock A 25,000 $0.67 1,011,667 D M
30 Jan, 2026 John M. Evans Common Stock D 22,094 $28.27 989,573 D S
30 Jan, 2026 John M. Evans Common Stock D 2,906 $29.00 986,667 D S
29 Jan, 2026 John M. Evans Stock Option (Right to Buy) D 19,336 $0.00 0 D M
29 Jan, 2026 John M. Evans Stock Option (Right to Buy) D 5,664 $0.00 93,672 D M
30 Jan, 2026 John M. Evans Stock Option (Right to Buy) D 25,000 $0.00 68,672 D M
31 Jan, 2026 John M. Evans Stock Option (Right to Buy) A 180,000 $0.00 180,000 D A
22 Jan, 2026 Christine Bellon Common Stock D 1,371 $34.00 95,667 D S